Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

642 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nurse migration in Europe--can expectations really be met? Combining qualitative and quantitative data from Germany and eight of its destination and source countries.
Zander B, Blümel M, Busse R. Zander B, et al. Among authors: busse r. Int J Nurs Stud. 2013 Feb;50(2):210-8. doi: 10.1016/j.ijnurstu.2012.11.017. Epub 2012 Dec 25. Int J Nurs Stud. 2013. PMID: 23273435
Nurses' reports on hospital care in five countries.
Aiken LH, Clarke SP, Sloane DM, Sochalski JA, Busse R, Clarke H, Giovannetti P, Hunt J, Rafferty AM, Shamian J. Aiken LH, et al. Among authors: busse r. Health Aff (Millwood). 2001 May-Jun;20(3):43-53. doi: 10.1377/hlthaff.20.3.43. Health Aff (Millwood). 2001. PMID: 11585181
Disease management programs in Germany's statutory health insurance system.
Busse R. Busse R. Health Aff (Millwood). 2004 May-Jun;23(3):56-67. doi: 10.1377/hlthaff.23.3.56. Health Aff (Millwood). 2004. PMID: 15160803
Policies for disease prevention in Germany in the European context: a comparative analysis.
Gericke CA, Busse R. Gericke CA, et al. Among authors: busse r. J Public Health (Oxf). 2004 Sep;26(3):230-8. doi: 10.1093/pubmed/fdh149. J Public Health (Oxf). 2004. PMID: 15454589
Determining the "Health Benefit Basket" of the Statutory Health Insurance scheme in Germany: methodologies and criteria.
Busse R, Stargardt T, Schreyögg J. Busse R, et al. Eur J Health Econ. 2005 Dec;Suppl(Suppl 1):30-6. doi: 10.1007/s10198-005-0316-z. Eur J Health Econ. 2005. PMID: 16270210 Free PMC article. Review.
Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures?
Busse R, Schreyögg J, Henke KD. Busse R, et al. Int J Health Plann Manage. 2005 Oct-Dec;20(4):329-49. doi: 10.1002/hpm.818. Int J Health Plann Manage. 2005. PMID: 16335081
Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries.
Schreyögg J, Stargardt T, Tiemann O, Busse R. Schreyögg J, et al. Among authors: busse r. Health Care Manag Sci. 2006 Aug;9(3):215-23. doi: 10.1007/s10729-006-9040-1. Health Care Manag Sci. 2006. PMID: 17016927
Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system?
Schreyögg J, Tiemann O, Busse R. Schreyögg J, et al. Among authors: busse r. Health Care Manag Sci. 2006 Aug;9(3):269-79. doi: 10.1007/s10729-006-9094-0. Health Care Manag Sci. 2006. PMID: 17016933
Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
Stargardt T, Schreyögg J, Busse R. Stargardt T, et al. Among authors: busse r. Health Policy. 2007 Nov;84(1):30-8. doi: 10.1016/j.healthpol.2007.04.006. Epub 2007 Jun 5. Health Policy. 2007. PMID: 17553587
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA. Stargardt T, et al. Among authors: busse r. J Ment Health Policy Econ. 2008 Jun;11(2):89-97. J Ment Health Policy Econ. 2008. PMID: 18509216
642 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback